In today’s Pharma Pulse, the FDA expands a key biologic approval for pediatric patients, and new research highlights the ...

For those managing pharmaceutical supply chains, the transition to low-carbon heat is no longer elective. Evolving regulatory ...

Ongoing conflict in the Middle East has pushed pharmaceutical companies into cold chain rerouting scrambles. Conflict in the ...

A $3 billion China investment targets localized oral solid-dose manufacturing and supply-chain redundancy to support ...

In today’s Pharma Pulse, Eli Lilly issues a safety warning and SteinCares enters a licensing agreement with Shilpa Biologicals to expand biosimilar access in Latin America. Welcome to Pharma Pulse, a ...

Kroger’s retail rollout shifts Zepbound KwikPen distribution from direct-to-consumer to community pharmacy channels, potentially reducing friction in initiation and refills for GLP-1 obesity therapy.

In today’s Pharma Pulse, Antengene and UCB ink a $1.18 billion global deal for ATG-201 to target autoimmune diseases, while ...

Orphan drugs are forecast to surpass $400 billion in 2032 sales, driven by accelerating rare disease innovation despite regulatory volatility, pricing pressures, and capital competition from ...

SpotSee and Controlant announced a collaboration to enhance pharmaceutical supply chain visibility using integrated ...

In a recent interview, Jay Bregman, founder and CEO of Andel, discussed his company's newly launched direct-to-employer ...